Stay updated on Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page.

Latest updates to the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page
- Check7 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a new revision of the page content. This reflects a small update to the page history metadata without altering study details.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe latest revision tag in the history is updated to v3.5.4, replacing the previous v3.5.3 tag.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page’s software revision marker was updated from v3.5.2 to v3.5.3, indicating a platform/version change rather than a modification to the trial’s record history.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check86 days agoChange DetectedAdded a new record version v3.5.0 and removed v3.4.3 from the history.SummaryDifference0.1%

- Check93 days agoChange DetectedA new revision entry v3.4.3 was added and the previous revision v3.4.2 was removed from the history.SummaryDifference0.1%

Stay in the know with updates to Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin/Etoposide +/- Atezolizumab in ES-SCLC Clinical Trial page.